1. Home
  2. WINT vs BLMZ Comparison

WINT vs BLMZ Comparison

Compare WINT & BLMZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WINT
  • BLMZ
  • Stock Information
  • Founded
  • WINT 1992
  • BLMZ 2017
  • Country
  • WINT United States
  • BLMZ Japan
  • Employees
  • WINT N/A
  • BLMZ N/A
  • Industry
  • WINT Biotechnology: Biological Products (No Diagnostic Substances)
  • BLMZ
  • Sector
  • WINT Health Care
  • BLMZ
  • Exchange
  • WINT Nasdaq
  • BLMZ NYSE
  • Market Cap
  • WINT 2.2M
  • BLMZ 2.3M
  • IPO Year
  • WINT 1995
  • BLMZ 2024
  • Fundamental
  • Price
  • WINT $0.92
  • BLMZ $0.22
  • Analyst Decision
  • WINT Hold
  • BLMZ
  • Analyst Count
  • WINT 1
  • BLMZ 0
  • Target Price
  • WINT $350.00
  • BLMZ N/A
  • AVG Volume (30 Days)
  • WINT 25.7M
  • BLMZ 33.8M
  • Earning Date
  • WINT 08-18-2025
  • BLMZ 02-15-2025
  • Dividend Yield
  • WINT N/A
  • BLMZ N/A
  • EPS Growth
  • WINT N/A
  • BLMZ N/A
  • EPS
  • WINT N/A
  • BLMZ N/A
  • Revenue
  • WINT N/A
  • BLMZ $1,535,822.00
  • Revenue This Year
  • WINT N/A
  • BLMZ N/A
  • Revenue Next Year
  • WINT N/A
  • BLMZ N/A
  • P/E Ratio
  • WINT N/A
  • BLMZ N/A
  • Revenue Growth
  • WINT N/A
  • BLMZ 71.48
  • 52 Week Low
  • WINT $0.36
  • BLMZ $0.06
  • 52 Week High
  • WINT $737.44
  • BLMZ $3.36
  • Technical
  • Relative Strength Index (RSI)
  • WINT 54.04
  • BLMZ N/A
  • Support Level
  • WINT $0.91
  • BLMZ N/A
  • Resistance Level
  • WINT $1.20
  • BLMZ N/A
  • Average True Range (ATR)
  • WINT 0.22
  • BLMZ 0.00
  • MACD
  • WINT 0.01
  • BLMZ 0.00
  • Stochastic Oscillator
  • WINT 23.61
  • BLMZ 0.00

About WINT Windtree Therapeutics Inc.

Windtree Therapeutics Inc is a biotechnology company focused on advancing early and late-stage therapies for critical conditions and diseases. Its portfolio of product candidates includes istaroxime, a Phase 2 candidate with sarco endoplasmic reticulum Ca2+ -ATPase 2a, or SERCA2a, activating properties for acute heart failure and associated cardiogenic shock, preclinical SERCA2a activators for heart failure, rostafuroxin for the treatment of hypertension in patients with a specific genetic profile, and a preclinical atypical protein kinase C iota, or aPKCi, inhibitor, being developed for potential application in rare and broad oncology indications. It operates in one operating segment, which is the research and development of products focused on cardiovascular disease.

About BLMZ BLOOMZ INC

BloomZ Inc operates as an audio-producing and voice actor managing company. The company provides audio production services and voice-acting educational services in Japan. The business lines of the company are the audio production business, the VTuber management business, and the voice actor workshop business. The audio production comprises producing audios for animations and video games using dubbing, BGM producing, and mixing techniques; the Vtuber management business creates motion-capture technology for streamers to provide the voice to stream real-time videos featuring human facial expressions and gestures; and the voice actor workshop provides practical voice acting services.

Share on Social Networks: